Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 376 to 400
-
Meeting statementsCommunique from the fourth meeting of the TGACC
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for the year 2018-19
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
TGA laboratory testing reportsReport on TGA Laboratories review of the surface of 52 different models of breast implants and tissue expanders
-
Scheduling decisions (final)Delegate-only final decisions and reasons for New Chemical Entities (NCEs) - 1 October 2019 implementation date
-
Meeting statementsThe TGA hosted a stakeholder forum in Melbourne on 10 October 2018
-
Corporate reportsThe TGA thanks respondents who provided submissions
-
Scheduling submissionsPublic submissions in response to the June 2019 ACMS/ACCS/Joint meetings
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 10 October 2019
-
Meeting statementsAdvisory Committee on Medicines
-
TGA laboratory testing reportsThis testing project was designed to assess compliance with the new Standard
-
Corporate reportsA fact sheet to support consumers following a recall of Allergan Biocell breast implants.
-
Corporate reportsSummary of our actions following the 2018 TGA stakeholder survey
-
Scheduling decisions (final)Notice of final decisions on amendments to the Poison Standard in relation to substances considered at ACMS #26, ACCS #24, Joint ACMS-ACCS #21 (March 2019) and delegate only decisions.
-
Corporate reportsYou can help by sharing our messages on social media, your website and around your workplace.
-
Scheduling submissionsPublic submissions in response to the March 2019 ACMS/ACCS/Joint interim decision
-
Scheduling submissionsOutcomes of the public consultation on Appendix M of the Poisons Standard are now available
-
-
Meeting statementsCommunique from the third meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Scheduling decisions (final)Final decision on the scheduling of alkyl nitrites - a matter which was most recently referred to the March 2019 Joint Advisory Committees on Medicines and Chemicals Scheduling (Joint ACMS-ACCS#21).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 4 July 2019
-
Corporate reports
-
TGA laboratory testing reportsTGA Laboratories has released a report detailing testing of alkyl nitrite products
-
Scheduling decisions (final)Delegate-only scheduling final decisions are now available